Although Taiwan is not an area where cholera is endemic, from October 1988 to October 1997 30 episodes of non -O1, non -O139 Vibrio cholerae infection were noted at the National Cheng Kung University Hospital in Taiwan. Infections generally occurred in hot seasons, and two episodes were concomitant with Vibrio vulnificus infection. Three major clinical presentations were found: bacteremia with concurrent spontaneous bacterial peritonitis or invasive soft-tissue infections that occurred solely in cirrhotic patients; self-limited acute febrile gastroenteritis that occurred in patients with no underlying medical disease; and necrotizing fasciitis or cellulitis that often resulted from a wound on extremities. Other manifestations included fatal pneumonitis in a drowned man and acute pyosalpinx. The differential diagnosis of invasive infections in cirrhotic patients should include infections due to non-O1 V. cholerae or V. vulnificus, and a third-generation cephalosporin and a tetracycline analogue or a fluoroquinolone alone is recommended for treatment of severe vibrio infections.
In Vitro Antibiotic Susceptibility Testing
intestinal diseases, often occurring in immunocomproTwenty-six isolates of V. cholerae were available for in vitro mised persons [3, 4] .
antibiotic susceptibility testing by means of the Kirby-Bauer Suggestive clinical clues for V. cholerae infections include method with use of Mueller-Hinton agar. Drugs tested included travel, seawater or freshwater exposure, or ingestion of raw the following (mg per disk): gentamicin (10) , amikacin (30), seafood [5] . Because Taiwan is a subtropical island, a natural ampicillin (10) , piperacillin (100), ampicillin/sulbactam (10/ environment suitable for the growth of V. cholerae, and an 10), ticarcillin/clavulanate (75/10), piperacillin/tazobactam area where chronic hepatitis B virus infection is hyperendemic, (100/10), cephalothin (30), cefuroxime (30), cefixime (5) , cefthere are many people with postnecrotic cirrhosis who are sustriaxone (30), cefotaxime (30), ceftazidime (30), imipenem ceptible to invasive infections due to V. cholerae. To elucidate (10) , norfloxacin (10) , ofloxacin (5) , ciprofloxacin (5) , tetracythe clinical presentations of and the morbidity and mortality cline (30), minocycline (30), chloramphenicol (30), and tricaused by non -O1 V. cholerae infections in Taiwan, a retromethoprim-sulfamethoxazole (1.25/23.75) . The guidelines of spective case survey in a university hospital was conducted.
the performance procedures and the breakpoint diameters for interpretation of the National Committee for Clinical Laboratory Standards were used [6] .
lysis on a blood agar plate, growth of yellow colonies on thiowere male. The mean age of the patients with bacteremia was 56 years (range, 38 to 79 years). Without exception, all 15 sulfate citrate bile salts sucrose agar, susceptibility to 10 mg and 150 mg of vibriostatic agent O-129 (Rosco, Tåstrup, Denmark), patients had hepatic cirrhosis, and 13 had decompensated hepatic function (those with scores §10 were classified as Pugh tolerability to 1% salt solution, and intolerability to 10% salt solution were identified as V. cholerae. Typical biochemistry class C). Coexisting underlying diseases included gallbladder stones (4 cases), hepatoma (4), diabetes mellitus (1), and conprofiles for V. cholerae included positive nitrate reduction, indole production, catalase production, citrate utilization, gestive heart failure (2). Two patients had polymicrobial bacteremia: one had concomitant Vibrio vulnificus bacteremia, and Voges-Proskauer test, ornithine decarboxylase production, and lysine decarboxylase production and negative arginine dihydroone had Escherichia coli bacteremia. Only two patients had contact with raw seafood before the infectious episode. lase production and urea hydrolysis [7, 8] ; these characteristics were noted by the API 20E System (bioMérieux Vitek, HaAll infections were community-acquired. Initial clinical presentations included fever (14 cases), chills (11), abdominal pain zelwood, MO) or by traditional biochemistry reactions in test tubes. Serotyping was determined with use of O1 antiserum (9), and diarrhea (9). Hypotension was noted in 10 patients.
The leukocyte count at the onset of bacteremia ranged from (Difco Laboratories, Detroit) and O139 antiserum (Denka Seiken, Tokyo figure  2 (right panel). The outcome for cirrhotic patients with was defined as death occurring after at least 96 hours of hospitalization and before discharge from the hospital. The degree V. cholerae bacteremia was poor. Seven patients (47%) died. Early mortality was noted in five cases: four were directly of decompensation of hepatic cirrhosis was assessed by the scoring system proposed by Pugh et al. [9] that is based on attributed to sepsis itself, and one was due to sepsis and hepatoma rupture. Late mortality due to hepatic failure was noted serum albumin and bilirubin levels, prolongation of prothrombin time, amount of ascites, and degree of hepatic encephalopin two cases. athy.
Acute Gastrointestinal Infections

Results
During an 8-year period at NCKUH, 30 V. cholerae isolates There were eight cases of acute gastroenteritis (table 3) . No gender predominance was found (four males and four females). from 30 different patients were identified. All isolates were non-O1, non-O139 serotypes; these identifications were conThe mean age of the patients was 37.8 years (range, 22 to 51 years), which was younger than that for patients with bacterfirmed by the reference laboratory. Infections due to these isolates generally occurred in hot-weather months, especially from emia. None of the patients had chronic underlying illnesses. Copathogens were discovered in fecal specimens from two May to September (figure 1). In vitro antibiotic susceptibility testing by the disk diffusion method showed that non-O1 patients: Vibrio parahaemolyticus and Plesiomonas shigelloides, respectively. The prehospital courses were short (range, V. cholerae was susceptible to many drugs, including combinations of a b-lactam agent and a b-lactamase inhibitor, broad-õ24 to 72 hours). These eight patients presented with watery diarrhea (8 cases), fever (temperature, 38.2 -39.2ЊC; 6), abdomspectrum b-lactam agents, aminoglycosides, and fluoroquinolones (table 1) . According to the sites of infection, cases due inal cramps (6) , nausea or vomiting (6) , and chills (4). One patient initially had watery diarrhea without fever and later had to these agents were categorized into three groups: bacteremia, gastrointestinal infections, and other infections.
self-limited bloody stools. Leukocytosis (leukocyte count, 12,800 to 26,400/mm 3 ; mean, 19,042/mm 3 ) was noted in seven cases; in contrast, plateBacteremia let counts (188,000 to 329,000/mm 3 ; mean, 230,625/mm 3 ) were normal in all cases. Hospital courses in all cases were short One-half of the 30 isolates were recovered from blood; therefore, bacteremia was the most common presentation of V. chol-(1 -2 days) and no sequelae occurred, regardless of whether the patient was treated with antibiotics. erae infection ( 
Nonbacteremic, Nonintestinal Infections
All four patients with soft-tissue infections had prior minor trauma that provided a portal of entry for bacteria. Two of Seven strains were isolated from specimens other than blood these patients had contact with clam and fish 1 and 2 days, or feces (table 4) . Three strains were isolated from surgical respectively, before their admissions. Another patient's right specimens from the extremities of patients with necrotizing arm was stuck by an unknown plant 5 days prior to the infecfasciitis. These three patients had certain underlying diseases:
tion. Antibiotic therapy, a cephalosporin with or without a chronic hepatic disease (two cases) and congestive heart failure tetracycline analogue, and surgical fasciotomy, in cases of nec-(one case). In the latter case (case 1 in table 4), small bullae rotizing fasciitis, cured all four of these patients. and a purpuric, necrotic skin lesion were found (figure 2, left One strain, accompanied by V. vulnificus, was isolated from panel). One additional strain was isolated from a traumatic a sputum sample from a patient who had drowned in a contamiwound specimen from a diabetic patient with cellulitis. nated pond and subsequently died of bilateral aspiration pneumonia, acute respiratory distress syndrome, and septic shock. Another strain was recovered from the salpinx uterina of a [12] . In such an area where both organisms are endemic, non- non-O1 V. cholerae septicemia associated with soft-tissue insuch as cirrhosis, hematologic malignancies [3] , or other immunosuppressed conditions [18 -20] . The predominance of cirfection have often been described as having localized cellulitis with small bullous lesions [13 -15] . We found that dermatorhotic patients in our series probably reflects a high prevalence of postnecrotic cirrhosis in the community. In addition to prilogic presentations of patients with necrotizing soft-tissue infections caused by V. cholerae and V. vulnificus were similar mary bacteremia, secondary bacteremia with invasive soft-tissue infections and SBP were typical patterns. The relevant [16] , except that hemorrhagic bullae caused by V. cholerae seemed fewer and smaller.
explanations for the mechanism of invasive vibrio infections frequently occurring in patients with cirrhosis remain obscure; Host susceptibility is important not only for bacteremia caused by non-O1 V. cholerae but also for that caused by other there are many hypotheses, such as decreased serum bactericidal activity, impaired filtration function in the cirrhotic liver, Vibrio species [17] . Non -O1 V. cholerae bacteremia has often been described in individuals with certain underlying disorders, or increased serum iron levels [21] , but the precise role of each / 9c57$$oc34 09-16-98 11:26:50 cidal UC: CID water or seafood before the onset of V. cholerae infection. However, because of the retrospective nature of this study, the proportion of patients with a history of travel, exposure to contaminated water, or ingestion of undercooked seafood was probably underestimated. Both the occurrence of extraintestinal infections and the exposure histories suggest that non -O1 V. cholerae can be acquired from the environment. Because of the lack of a controlled clinical comparison, the optimal therapeutic regimen for invasive non -O1 V. cholerae infections remains unsettled. Clinical experiences with the treatment of other vibrio infections may serve as a model. The fact that ampicillin (despite in vitro susceptibility) has been dropped as an agent of therapy for cholera [3] and the fact that resistance of non -O1 strains to ampicillin has been increasingly reported [22] make this agent no longer indicated as infections [2] ; however, there was increasing resistance to tetraemia who presented with swelling, tenderness, and erythema over the cycline in our non -O1 V. cholerae isolates, and minocycline left lower leg had subcutaneous abscess formation around the ankle.
was more active than tetracycline.
Recently, our research group demonstrated that a combination regimen (cefotaxime plus minocycline) showed a synerdefense mechanism defect requires further studies. Previously gistic antibacterial effect in vitro [23] and in mice experimenreported crude case-fatality rates among cirrhotic patients with tally infected by V. vulnificus [24] , another dangerous non-O1 V. cholerae bacteremia have been high (ranging from halophilic organism for cirrhotic patients. Our clinical experi-23.8% [10] to 61.5% [3] ), and the case-fatality rate in our ence with the treatment of V. vulnificus infection also favored series was 47%. The poor outcome appears in part to be related such a regimen. In this series, three patients with necrotizing to preexisting cirrhosis.
fasciitis (case 8 in table 2 and cases 2 and 4 in table 4 ) who Of 21 patients with significant extraintestinal infections, were treated with cefotaxime and minocycline or doxycycline seven (33%) had invasive soft-tissue infections, necrotizing and fasciotomy survived. Although there is no prospective clinfasciitis, or cellulitis with or without bacteremia. Six patients ical data to verify the clinical efficacy of this particular combination, it seems reasonable to administer combination therapy (29%) had histories of contact with potentially contaminated for severe non -O1 V. cholerae infections. Newer quinolones Acute gastroenteritis is well recognized as the most common manifestation of non -O1 V. cholerae infection and can occur were extremely active against serotypes O1 and O139 and non -O1 V. cholerae for which the MIC 90 was 0.5 mg/mL [22] , sporadically or as an outbreak. Usually, it is a self-limited diarrheal illness of short duration, but the median duration of and these agents will theoretically be another good choice for treatment of invasive non -O1 V. cholerae infections.
illness has been reported to be up to 6.4 days [25] . Patients with 
